NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 50 of 57 results found.

Activity Company Description Location
Company StrideBio Inc. Activity: Research and Development Research and Development Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs). Location Research Triangle Park
Company Adrenas Therapeutics Inc. Activity: Research and Development Research and Development Company Description Adrenas Therapeutics, a Bridge Bio subsidiary, is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. Location Raleigh
Company Altis BioSystems Inc. Activity: Research and Development Research and Development Company Description Altis Biosystems has developed a patent-pending stem cell platform that recreates the human intestinal epithelium, in a high-throughput format, for compound screening and microbiome research for biopharmaceutical companies. Location Durham
Company Artizan Biosciences Inc. Activity: Research and Development Research and Development Company Description Artizan is developing a platform for identifying and targeting pathogenic intestinal bacteria, with a focus on inflammatory bowel disease and potential applications in autoimmune diseases, obesity, skin, lung and central nervous system diseases. Location Durham
Company AskBio Activity: Research and Development Research and Development Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. Location Research Triangle Park
Company Atsena Therapeutics Inc. Activity: Research and Development Research and Development Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. Location Durham
Company Bavarian Nordic Inc. Activity: Research and Development Research and Development Company Description Bavarian Nordic develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. Location Morrisville
Company Bedrock Therapeutics Inc. Activity: Research and Development Research and Development Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. Location Raleigh
Company BioCryst Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. Location Durham
Company BioCytics Inc. Activity: Research and Development Research and Development Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is incubated within the Carolina BioOncology Institute. Location Huntersville
Company Biorg Inc. Activity: Research and Development Research and Development Company Description Biorg is developing and commercializing organoid technology for use in life science applications such as diagnostics, drug screenings and toxicology. Location Winston-Salem
Company Celldom Inc. Activity: Research and Development Research and Development Company Description Celldom is developing next generation, high throughput single cell analysis technology with applications in research, drug discovery and drug development. Its technology enables the investigation of diversity in large cell populations. Location Durham
Company Cellective BioTherapy Inc. Activity: Research and Development Research and Development Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. Location Research Triangle Park
Company Cereius Inc. Activity: Research and Development Research and Development Company Description Cereius is developing novel radio-labeled therapeutics for treating solid tumor brain metastasis. Location Durham
Company CLAIRIgen Activity: Research and Development Research and Development Company Description CLAIRIgen develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. Location Durham
Company Couragen Biopharmaceutics LLC Activity: Research and Development Research and Development Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. Location Chapel Hill
Company Cytex Therapeutics Inc. Activity: Research and Development Research and Development Company Description Cytex Therapeutics develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. Location Durham
Company Data Driven Bioscience Inc. Activity: Research and Development Research and Development Company Description Data Driven Bioscience uses genomic tests, datasets and machine learning solutions to enable hospitals and pharmaceutical companies to diagnose cancer and personalize cancer treatment. Location Durham
Company Dualogics LLC Activity: Research and Development Research and Development Company Description Dualogics researches and develops bispecific antibody products based on their proprietary OrthoMab platform. Location Durham
Company Eldec Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. Location Chapel Hill
Company Enzerna Biosciences Inc. Activity: Research and Development Research and Development Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. Location Chapel Hill
Company Enzyvant Inc. Activity: Research and Development Research and Development Company Description Enzyvant develops therapeutics for treatment of rare diseases. Their focuses are RVT-802, an investigational tissue-based therapy for immune deficiency resulting from DiGeorge Anomaly, and RVT-801, an enzyme replacement therapy to treat Farber disease. Location Durham
Company EpiCypher Inc. Activity: Research and Development Research and Development Company Description EpiCypher develops and manufactures novel products and tools for epigenetics and chromatin biology, focused on enabling drug discovery research and development. Location Durham
Company Epigenos Biosciences Inc. Activity: Research and Development Research and Development Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage Cas9 technology to treat disease at the root of gene mis-regulation. Location Chapel Hill
Company Falcon Therapeutics Inc. Activity: Research and Development Research and Development Company Description Falcon Therapeutics develops genetically distinct cell therapy to treat solid tumors by turning a patient's own skin cells into "Trilogy Cells" that seek out and destroy cancer cells. Location Durham
Company FLAG Therapeutics Inc. Activity: Research and Development Research and Development Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. Location Raleigh
Company Foundation Medicine Inc. Activity: Research and Development Research and Development Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. Location Morrisville
Company GeneCentric Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. Location Research Triangle Park
Company GeneVentiv Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneVentiv Therapeutics is a gene therapy company developing a cure for Hemophilia A, Hemophilia B or Factor VIII deficiency, with or without inhibitors. Location Raleigh
Company GENIE Therapeutics Activity: Research and Development Research and Development Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. Location Winston-Salem
Company GSK Activity: Research and Development Research and Development Company Description GSK develops and manufactures vaccines, medicines and consumer healthcare products, with a focus on science related to the immune system, use of genetics and advanced technologies. Location Research Triangle Park
Company Gusto Global LLC Activity: Research and Development Research and Development Company Description Gusto Global integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. Location Research Triangle Park
Company Heat Biologics Inc. Activity: Research and Development Research and Development Company Description Heat Biologics develops immunotherapies to activate a patient's immune system against cancer. The company’s drugs are designed to take advantage of a natural biological process to robustly activate and stimulate T-cells. Location Morrisville
Company Humacyte Inc. Activity: Research and Development Research and Development Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. Location Durham
Company IndiOmics LLC Activity: Research and Development Research and Development Company Description Indiomics uses machine learning and protein biomarker expression levels to identify connections between human cells and common chemical exposures. Location Wilmington
Company Inivata Inc. Activity: Research and Development Research and Development Company Description Inivata develops a noninvasive liquid biopsy diagnostic using the precision of circulating tumor DNA (ctDNA) analysis for improving cancer detection and assessing individual response to treatment. Location Research Triangle Park
Company ISTARI Oncology Inc. Activity: Research and Development Research and Development Company Description ISTARI Oncology is developing immunotherapies for cancer treatment. Location Morrisville
Company Locus Biosciences Inc. Activity: Research and Development Research and Development Company Description Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed. Location Morrisville
Company Lucerno Dynamics LLC Activity: Research and Development Research and Development Company Description Lucerno Dynamics is commercializing a noninvasive device for quality assurance and control in nuclear medicine imaging. Future applications of the technology include rheumatoid arthritis, immunotherapy, nuclear medicine and chemotherapy assessment. Location Cary
Company Meryx Inc. Activity: Research and Development Research and Development Company Description Meryx is developing small-molecule, orally-bioavailable RTK inhibitors that inhibit growth and initiate anti-tumor immunity in hematologic and solid malignancies. Location Chapel Hill
Company NeuroGT Inc. Activity: Research and Development Research and Development Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. Location Durham
Company Path BioAnalytics Inc. Activity: Research and Development Research and Development Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. Location Durham
Company Pfizer (Morrisville) Activity: Research and Development Research and Development Company Description Pfizer develops bioreactors for large-scale manufacturing of gene therapies at the Morrisville location. Location Morrisville
Company Pfizer Inc. (Chapel Hill) Activity: Research and Development Research and Development Company Description Pfizer's Bamboo Therapeutics develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases, including Giant Axonal Neuropathy (GAN), Canavan Disease, Friedreich's Ataxia and Duchenne Muscular Dystrophy (DMD). Location Chapel Hill
Company PhosphoGam Inc. Activity: Research and Development Research and Development Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. Location Durham
Company Precise Bio Inc. Activity: Research and Development Research and Development Company Description Precise Bio grows live and vital complicated organs for transplant using 3D bio-printing. Location Winston-Salem
Company Precision BioSciences Inc. Activity: Research and Development Research and Development Company Description Precision BioSciences utilizes a proprietary genome editing method called ARCUS to treat cancers and genetic diseases, and enable the development of safer, more productive food sources. Location Durham
Company RainBio Inc. Activity: Research and Development Research and Development Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. Location Raleigh
Company Sanesco International Inc. Activity: Research and Development Research and Development Company Description Sanesco develops clinical tools for healthcare providers, such as neuroendocrine analytical testing, nutritional support formulas and patient-centered clinical review. The NeuroLab division conducts research and development of in vitro diagnostic tools. Location Arden
Company Sapere Bio Inc. Activity: Research and Development Research and Development Company Description Sapere Bio develops biomarkers of aging for clinical use to help physicians predict risk of chemotherapy-induced toxicities and surgery-associated adverse events in various patient groups. Location Research Triangle Park